pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
tango-therapeutics PRESS RELEASE ARCHIVE
Aug 3, 2021
Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference
Apr 14, 2021
Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies
Mar 24, 2021
Tango Therapeutics Appoints Mace Rothenberg, MD, and Lesley Ann Calhoun, CPA, to Board of Directors
Aug 17, 2020
Tango Therapeutics Announces $50 Million Equity Financing
Aug 17, 2020
Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
Apr 9, 2020
Tango Therapeutics Raises $60 Million Series B Financing and Strengthens Executive Team
Mar 16, 2020
Medivir and Tango Therapeutics Sign License Agreement for Preclinical Asset
Jul 8, 2019
Tango Therapeutics Appoints Reid Huber, PhD, to Board of Directors
Oct 31, 2018
Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies
Oct 10, 2018
Tango Therapeutics Appoints Malte Peters, MD, to Board of Directors
May 10, 2018
Tango Therapeutics Bolsters Expertise in Oncology Translational Research and Clinical Pharmacology with Leadership Expansion
Mar 8, 2018
Tango Therapeutics Expands Board of Directors with the Addition of Leading Oncology Experts with Deep Experience in Targeted and Personalized Therapies
Dec 6, 2017
Tango Therapeutics Announces the Addition of Shakti Narayan, Ph.D., J.D. as Chief Business Officer
Sep 26, 2017
Tango Therapeutics Named a “Fierce 15” Company by FierceBiotech
Sep 25, 2017
Tango Therapeutics Appoints Barbara Weber, M.D., as Chief Executive Officer
Mar 30, 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
